Steven Davis, MD
Otolaryngology · Torrance, CANPI 1063435675
Payments from drug & device makers
Across 379 payments — averaging $1435.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$136K
- Spirair, Inc.$126K
- Aerin Medical Inc.$74K
- Optinose US, Inc.$47K
- Biohaven Pharmaceutical Holding Company Ltd.$38K
- Regeneron$27K
- plus $97K from 21 others
Across 31 payments — averaging $4768.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Neurent Medical Limited$75K
- Aerin Medical Inc.$72K
- Optinose US, Inc.$774
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 55 | $135,761 |
| Spirair, Inc. | 9 | $125,931 |
| Aerin Medical Inc. | 47 | $73,859 |
| Optinose US, Inc. | 67 | $46,948 |
| Biohaven Pharmaceutical Holding Company Ltd. | 29 | $38,185 |
| Regeneron | 32 | $26,796 |
| Sanofi US Services Inc. | 2 | $18,505 |
| Medtronic(2 entities) | 37 | $16,329 |
| Paratek Pharmaceuticals, Inc. | 1 | $15,147 |
| Pfizer | 3 | $14,408 |
| Eli Lilly | 1 | $12,000 |
| Arrinex, Inc. | 2 | $11,682 |
| Genentech USA, Inc. | 6 | $5,985 |
| Regeneron Healthcare Solutions, Inc. | 21 | $777 |
| Sanofi | 21 | $544 |
| GSK | 23 | $497 |
| Galderma Laboratories, L.p. | 5 | $183 |
| Neurent Medical Limited | 5 | $124 |
| Smith+Nephew | 3 | $112 |
| Genentech, Inc. | 2 | $100 |
| KARL Storz Endoscopy-america | 1 | $48 |
| Intersect ENT, Inc. | 2 | $46 |
| Acclarent, Inc | 1 | $31 |
| Merck | 1 | $23 |
| AbbVie | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Kaleo, Inc. | 1 | $18 |
How this compares
$544,073 in reported general payments places this provider in the 95th percentile of 1,021 otolaryngology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other otolaryngology in Torrance
- Brett LevineTorrance$46K
- Randall OwRoseville$4.3M
- Amir MoradiVista$2.6M
- Brian WeeksSan Diego$1.6M
- Charles LimbSan Francisco$1.5M
- Andrew BerosSan Diego$688K
- Paul SchalchChula Vista$573K
- Arnaud BewleySacramento$541K
- Keith BlackwellLos Angeles$349K
- Kalpna DurairajSun Valley$348K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.